HIGHLIGHTS
- who: Silvia Giannattasio and collaborators from the University of Siena, Italy have published the article: Cell-Target-Speci c Anti-In fl ammatory Effect of Empagli ozin: In Vitro Evidence in Human Cardiomyocytes, in the Journal: (JOURNAL)
- what: The aim of this preliminary study was to explore whether human cardiomyocytes within the Th1-inflammatory microenvironment are directly affected by Empa, in terms of CXCL10 targeting.
SUMMARY
Of note, Frontiers in Molecular Biosciences | www.frontiersin.org May 2022 | Volume 9 | Article 879522 Empagliflozin Inhibits Inflammation in Human Cardiomyocytes Empa-induced cardioprotection seems . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.